BIODELIVERY SCIENCES INTERNATIONAL (BDSI) 09/06/2016 www.bdsi.com Pipeline: Focus mainly on developing products for pain management and addiction. Product Indication Status Onsolis (Fentanyl buccal film) Breakthrough cancer pain Approved Bunavail (Buprenorphine/Naloxone buccal film) Opioid dependence Approved Belbuca (Buprenorphine buccal film) Chronic pain Approved Clonidine topical gel Painful diabetic neuropathy Phase 3 Buprenorphine depot injection Opioid dependence/Chronic pain Formulation development
www.bdsi.com Pipeline: Focus mainly on developing products for pain management and addiction. Product Indication Status Onsolis (Fentanyl buccal film) Breakthrough cancer pain Approved Bunavail (Buprenorphine/Naloxone buccal film) Opioid dependence Approved Belbuca (Buprenorphine buccal film) Chronic pain Approved Clonidine topical gel Painful diabetic neuropathy Phase 3 Buprenorphine depot injection Opioid dependence/Chronic pain Formulation development
